Q2 2023 Holdings
Filed 2023-08-14 | 13 holdings | $180.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $30.6M | 858,474 | 17.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $28.4M | 448,987 | 15.7% |
| Ishares Russell 2000 ETF TR(IWM)Put | UNIT | 464287655 | $28.1M | 150,000 | 15.6% |
| Merus N V | COM | N5749R100 | $20.4M | 775,109 | 11.3% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $17.4M | 870,114 | 9.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $15.5M | 623,941 | 8.6% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $15.0M | 651,325 | 8.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $7.2M | 1,312,233 | 4.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $6.6M | 174,648 | 3.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $6.4M | 16,315 | 3.5% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $2.3M | 250,000 | 1.3% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $2.1M | 760,657 | 1.2% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $546.7K | 3,303,190 | 0.3% |